id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-327403-adwj2xq7	Speth, Marlene M.	Mood, anxiety and olfactory dysfunction in COVID‐19: evidence of central nervous system involvement?	2020-07-02		.txt	text/plain	3443	201	53	The 2‐item Patient Health Questionnaire (PHQ‐2) and the 2‐item Generalized Anxiety Disorder questionnaire (GAD‐2) were used to measure depressed mood and anxiety level, respectively, at enrollment and for participants' baseline, pre‐COVID‐19 state. [1] [2] [3] COVID-19 has classically been described by symptoms of fever, cough, and shortness of breath as well as constitutional symptoms such as fatigue and myalgias, 2,4,5 although more recent studies have described a myriad of other COVID-19 clinical manifestations including chemosensory dysfunction, i.e. decreased sense of smell and taste. We found that depressed mood and anxiety were positively associated with COVID-19 symptoms of decreased sense of smell and taste. 32 However, in the setting of the COVID-19 pandemic and wide public recognition of the potential lethality of SARS-CoV-2 infection, we report here that the severities of classic and worrisome symptoms of COVID-19-such as fever, cough or SOB-were not associated with emotional disturbance while chemosensory dysfunction was.	./cache/cord-327403-adwj2xq7.txt	./txt/cord-327403-adwj2xq7.txt